MusclePharm slammed home its first profitable year in company history, as the sports nutrition brand finally sees some fruits of its labor stemming from the extensive multi-year turnaround plan. For this podcast episode, I'll utilize the MusclePharm Corporation (OTCMKTS: MSLP) 2020Q4 earnings report, that was released on 3/30/2021, to breakdown the most important key updates surrounding the maker of Combat protein powder. With profitability now being achieved consistently, where does MusclePharm go from here? While the sports nutrition brand is obviously far from rewriting its history of accumulated operating losses, these results are baby steps in the right direction. It must now focus on; stabilizing falling global sales, building direct-to-consumer (DTC) capabilities, understanding its legacy role in the market, and rebuilding investor relations to build stakeholder support and optionality for the business in the future.